首页> 中文期刊> 《四川医学》 >新型抗抑郁药在儿童情绪障碍中的临床应用

新型抗抑郁药在儿童情绪障碍中的临床应用

         

摘要

目的 比较新型抗抑郁药帕罗西汀、舍曲林、艾司西酞普兰在儿童情绪障碍中的应用.方法 共纳入使用帕罗西汀、舍曲林、艾司西酞普兰的儿童情绪障碍患者60例,根据病历病情记录分别在治疗前及治疗第2、4、6周末采用临床疗效总评量表(CGI)评定临床疗效,用不良反应量表(TESS)评定不良反应.结果 帕罗西汀组有效率为83.3%,舍曲林组有效率为88.9%,艾司西酞普兰组有效率为91.7%.总有效率为86.7%.不良反应发生率帕罗西汀组为20%,舍曲林组为22.2%,艾司西酞普兰为25%.结论 新型抗抑郁药对儿童情绪障碍安全有效.%Objective To compare the clinical usage of new type antidepressant drugs - paroxetine, sertraline, escitalo-pram in emotional disorders of Childrenhood. Methods 60 cases of emotional disorders of childrenhood were treated with paroxetine , sertraline, escitalopram were included in the study. The clinical efficacy of each patient was assessed with the Clinical Global Impression ( CGI) before treatment and at treatment of 2, 4, 6 weekend. The side effects were recorded by using Treatment Emergent Symptom Scale (TESS). Results The effective rate was 83. 3% in the paroxetine group, the sertraline group was 88. 9% , escitalopram effective rate was 91. 7%. The total effective rate was 86. 7%. The side effects of paroxetine group was 20% , the side effects of sertraline group was 22. 2% , and the side effects of escitalopram was 25%. Conclusion The new type antidepres-sants drugs are safe and effective for emotional disorders of childrenhood.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号